Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct 1;7(5):707-718.
doi: 10.2217/ahe.11.56.

The aging immune system and its relationship with cancer

Affiliations

The aging immune system and its relationship with cancer

Anthony D Foster et al. Aging health. .

Abstract

The incidence of most common cancers increases with age. This occurs in association with, and is possibly caused by a decline in immune function, termed immune senescence. Although the size of the T-cell compartment is quantitatively maintained into older age, several deleterious changes (including significant changes to T-cell subsets) occur over time that significantly impair immunity. This article highlights some of the recent findings regarding the aging immune system, with an emphasis on the T-cell compartment and its role in cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Age-associated changes characteristic of immunosenescence occur in T-cell populations
The young thymus supports more robust thymopoiesis with naive cells, which have the greatest T-cell receptor repertoire diversity and comprise the largest proportion of T cells. With aging, thymus involution occurs and there is progressive loss of T-cell receptor repertoire diversity with the decreased population of naive T cells and there is an enlarged memory component that secretes most type 1 and 2 cytokines. With repeated stimulation, the memory cells give rise to activated effector T cells, which are oligoclonal and have the most restricted T-cell receptor repertoire.

Similar articles

Cited by

References

    1. Fulop T, Kotb R, Fortin CF, Pawelec G, De Angelis F, Larbi A. Potential role of immunosenescence in cancer development. Ann. NY Acad. Sci. 2010;1197:158–165. - PubMed
    1. Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Aging, immunity and cancer. Curr. Opin. Immunol. 2004;16(2):151–156. - PubMed
    1. Hakim FT, Gress RE. Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens. 2007;70(3):179–189. - PubMed
    1. Sportès C, Hakim FT. Aging, immunity and cancer. In: Fulop T, Franceschi C, Hirokawa K, Pawelec G, editors. Handbook on Immunosenescence: Basic Understanding and Clinical Applications. Springer; Berlin, Germany: 2009.
    1. Schultzel M, Saltzstein SL, Downs TM, Shimasaki S, Sanders C, Sadler GR. Late age (85 years or older) peak incidence of bladder cancer. J. Urol. 2008;179(4):1302–1305. discussion 1305–1306. - PMC - PubMed

LinkOut - more resources